Ashly Jordan
Ashly E. Jordan, PhD, MPH
NYS Office of Addiction Services and Supports (OASAS) - Director of Research and Program Evaluation
PhD, Epidemiology, Graduate School of Public Health and Health Policy, City University of New York
MPH, Biostatistics and Epidemiology, School of Public Health, City University of New York
Research Interests
Societal (structural, social, and political) determinants of population health and inequities, infectious disease epidemiology, people who use drugs, hepatitis C virus, HIV, multi-level data analysis
Ashly Jordan is director of Research and Program Evaluation at the New York State Office of Addiction Services and Supports (OASAS). Dr. Jordan is a multi-disciplinary public health and research epidemiologist with over 15 years of experience in conducting applied public health research, surveillance, program, and evaluation work at the interface of viral hepatitis and other infectious diseases, poverty and structural inequities, and substance use. Drawing on theory-based multi-level understandings of illness and health, and principles of health equity and social justice, her research has focused on the interplay between individual, social, and structural factors. Dr. Jordan’s work employs rigorous quantitative and qualitative methods to better understand factors and policies which contribute to risk, and which could be modified to improve individual- and population-level health and well-being through treatment and prevention.


Nolen S, Trinidad AJ, Jordan AE, Green TC, Jalali A, Murphy SM, Zang X, Marshall BDL (2023).
Racial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
Harm Reduction Journal, 20 (1), 152. doi: 10.1186/s12954-023-00891-x. PMCID: PMC10585909.

Kapadia SN, Jordan AE, Eckhardt BJ, Perlman DC (2023).
The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination
Clinical Infectious Diseases [Epub 2023 Aug 27]. doi: 10.1093/cid/ciad503.

Jordan AE, Kashino W, Suhartono S, Campello G, Busse A (2023).
A systematic review and narrative synthesis of interventions to address substance use disorders and other mental health disorders in prison settings with a focus on low- and middle-income countries
Criminal Justice and Behavior, 50 (6), 787-805. doi: 10.1177/00938548231166155.

Jordan AE (2023).
Commentary on Iversen et al.: Adapting public health surveillance and monitoring to reflect how DAAs are changing the epidemiology of hepatitis C virus infection
Addiction, 118 (5), 912-913. doi: 10.1111/add.16139.

Jordan AE, Izar R, Nicolas R, Beharie N, Harocopos A (2022).
Understanding vaccine perceptions and willingness to receive COVID-19 vaccination: Opportunities to strengthen public health responses and COVID-19 services for people who use drugs
Vaccines, 10 (12), 2044. doi: 10.3390/vaccines10122044. PMCID: PMC9784169.


Jordan AE, Des Jarlais DC, Arasteh K, McKnight C, Nash D, Perlman DC (2015).
Incidence and prevalence of hepatitis C virus infection among persons who inject drugs in New York City: 2006-2013
Drug and Alcohol Dependence, 152, 194-200. doi: 10.1016/j.drugalcdep.2015.03.039. PMCID: PMC4458155.

Hagan H, Jordan AE, Neurer J, Cleland CM (2015).
Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men
AIDS, 29 (17), 2335-2345. doi: 10.1097/QAD.0000000000000834. PMCID: PMC4640945.

Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC (2015).
An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential
International Journal of Drug Policy, 26 (11), 1056-1063. doi: 10.1016/j.drugpo.2015.04.015. PMCID: PMC4581906.

Ashly Jordan's MyBibliography Profile